Shenzhen Changhong Technology Co. Ltd Class A

Shenzhen Changhong Technology Co. Ltd Class A

SSZSE:300151
14.35
CNY
-0.07
(-0.49%)
0.08EPS
182.54P/E
10.55BMarket Cap
Apr 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.25
2.91
1.11
1.12
1.21
1.34
1.39
2.52
2.52
2.49
1.77
1.94
1.85
1.83
Basic EPS, GAAP
0.07
0.26
0.06
0.06
0.07
0.11
0.12
0.38
0.25
0.26
0.06
0.19
0.12
0.11
Free Cash Flow per Basic Share
0.14
-0.31
-0.01
-0.01
0.05
0.02
0.04
0.17
-0.22
-0.27
-0.08
-0.1
-0.12
- -
Dividend per Share
0.04
0.06
0.03
0.03
0.03
0.03
0.06
- -
0.22
0.2
0.21
0.13
0.11
0.12
Book Value per Share
1.46
1.55
1.59
1.63
1.65
1.75
1.73
2.07
2.31
2.58
3.08
3.06
3.09
3.06
Tangible Book Value per Share
1.43
1.5
1.48
1.52
1.56
1.68
1.65
2
2.13
2.4
2.86
2.86
2.89
2.87
Basic Weighted Avg Shares
492
199
494
525
496
517
515
444
447
493
528
537
538
541
Sales/Revenue/Turnover
617
579
549
588
599
694
715
1,118
1,127
1,228
931
1,039
994
992
Operating Margin (%)
7.41
8.66
3.66
6.86
7.54
7.93
8.21
20.36
14.04
12.26
6.32
12.77
7.57
8.66
Depreciation Expense
22
23
32
37
35
33
36
43
65
70
72
75
70
- -
Net Income, GAAP
35
52
30
32
35
57
62
169
112
128
32
102
65
59
Effective Tax Rate (%)
20.41
14.77
12.06
20.86
4.47
7.45
8.7
14.25
11.22
10.78
50.66
20.5
32.05
27.58
Profit Margin (%)
5.74
8.94
5.41
5.35
5.79
8.2
8.64
15.1
9.92
10.44
3.4
9.81
6.5
5.92
Working Capital
548
520
474
473
486
514
393
481
897
846
1,031
790
789
343
LT Debt
- -
40
38
29
- -
- -
- -
34
455
541
525
484
609
209
Total Equity
735
778
811
832
847
896
883
1,073
1,199
1,349
1,691
1,659
1,654
1,629
Return on Invested Capital (%)
4.63
5.97
3.41
3.4
4.04
6.4
6.97
18.12
8.35
6.97
0.83
3.55
2.03
1.89
Return on Capital (%)
4.72
6.58
3.93
3.74
4.16
6.66
7.11
15.21
8.8
8.39
2.74
6.42
4.36
3.93
Return on Common Equity (%)
4.87
6.84
3.77
3.9
4.21
6.64
7.07
17.67
10.16
10.44
2.16
6.23
3.95
3.62

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
134
542
528
LT Borrowings
603
155
200
LT Finance Leases
9
11
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
533
533
533
Market Capitalization
8,062
13,286
10,554

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,087
997
1,051
Cash, Cash Equivalents & STI
582
427
433
Accounts Receivable, Net
179
183
226
Inventories
164
192
211
Total Current Liabilities
283
711
708
Payables & Accruals
- -
- -
- -
ST Debt
134
542
528
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.77%
9.47%
-0.28%
Free Cash Flow
-38.55%
-43.04%
17.53%
Net Income, GAAP
35.32%
18.2%
-36.66%
Sales/Revenue/Turnover
7.71%
-1.43%
-4.34%
Total Cash Common Dividend
1,840.37%
3,677.97%
-21.67%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
233
250
299
257
1,039
2025
249
249
- -
250
994
2026
239
220
281
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.04
0.07
0.04
0.19
2025
0.03
0.02
- -
0.03
0.12
2026
0.03
0.01
0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.06
0.06
- -
0.13
2025
0.01
0.08
- -
0.01
0.11
2026
0.02
0.09
- -
- -
- -

Company Description

CEO
Huan Chang Li
Full Time Employees
2,419
Sector
Process industries
Industry
Containers/Packaging
Address
No. 3 Jinlong Avenue Shenzhen GD China 518118
IPO Date
Dec 10, 2010
Business
Shenzhen Changhong Technology Co., Ltd. engages in the design, manufacture, and sale of precision molds and high-precision injection molded plastic parts. Its core products include medical devices and polymer plastic consumables, intelligent manufacturing products, semiconductor consumables, and mold products. The company provides integrated solutions for precision molds and automated production in the medical device, polymer plastics, intelligent manufacturing, and semiconductor sectors. It is recognized for its high-grade medical consumables and has received awards such as the National “Precision Mold Award.” The company primarily serves clients in China, with additional markets including Europe, Vietnam, and the Philippines. Founded in 2004 and headquartered in Shenzhen, Guangdong Province, China, it also maintains strategic relationships with leading domestic wafer factories and semiconductor manufacturers. Recent developments include Shenzhen Changhong Technology securing certification and ongoing delivery of semiconductor consumable products to major domestic wafer factories, with seven wafer carrier products under research and entering validation stages. The company is preparing for large-scale production in this segment. Its medical consumables sector maintains stable orders supported by long-term client relationships, with steady expansion of new clients and projects. Additionally, Shenzhen Changhong Technology formed a strategic alliance with Sinopec in 2024, marking a key partnership to explore technological innovation and industrial integration. The company reports ongoing efforts to enhance personnel training, ramp up production capacity, and focus on the precision plastic products market due to its larger capacity and growth potential. It mainly serves local markets in China, Vietnam, and the Philippines, with semiconductor business focused exclusively on domestic clients. In its latest quarterly results, the company reported revenue growth with some pressure on net income, reflecting its strategic investments in new product validations and market expansions.